Physician profile
Anne Patten
NPI 1164745121
$1,465.35
in general payments reported to CMS, 2019-2025
8 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $504 · 2022: $13.89 · 2023: $294 · 2024: $213 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $546.74 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $261.26 | 2021-2022 | |
| Abbott Laboratories | $158.83 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Janssen Pharmaceuticals, INC | $131.57 | 2021 | |
| Daiichi Sankyo INC. | $125.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.89 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $87.49 | 2025 | |
| Merck Sharp & Dohme LLC | $32.57 | 2025 | Verquvo, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Patten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.